Aurora Cannabis Pays Down $89 Million Credit Facility

Aurora Cannabis Completes Balance Sheet Restructuring

Full Repayment of Credit Facility Results in Principal and Interest Savings of ~$25 Million In the Next Year


EDMONTON, AB, June 1, 2021 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has completed the restructuring of its balance sheet. The second amended and restated credit facility, which matures on December 31, 2022, and consists of a term loan and revolver, was repaid in full, without penalty and at the Company’s discretion, in the amount of approximately $89 million, including accrued interest.

The repayment results in interest and scheduled principal repayment reductions of approximately $25 million over the next year based on the outstanding balance at the time of repayment. After giving effect to the repayment, the Company’s pro forma cash position was approximately $430 million as of May 31, 2021.

We are pleased to have completed our balance sheet restructuring through the full repayment of our credit facility. Since assuming the CEO role late last year, I recognized having a strong balance sheet is critical in what is a very dynamic industry.

Miguel Martin, Chief Executive Officer of Aurora Cannabis

Delivering on this priority allows us the ability to operate the business and pursue growth opportunities unconstrained by our balance sheet. Let me also express our appreciation to Aurora’s lenders who have provided us with exceptional support throughout this process.

“Following this repayment, we continue to have a substantial cash position and the financial flexibility needed to fund current operations and execute our business plan. Further, to maximize our strategic opportunities including within the U.S., we have an at-the-market equity program to issue and sell up to US$300 million of common shares. We are not expecting to access the ATM Program without an accretive use of proceeds,” he concluded.

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at

Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB”, and is a constituent of the S&P/TSX Composite Index.

Original press release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter